Retinal Capturing Articles & Analysis: Older

1 news found

Optina Diagnostics Receives Breakthrough Device Designation from U.S. FDA for a Retinal Imaging Platform to Aid in the Diagnosis of Alzheimer’s Disease

Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its retinal imaging platform (CAPRS1/MHRC2). Optina Diagnostics’ platform uses Artificial Intelligence (AI) to analyze the data rich hyperspectral retinal images captured with the MHRC during a simple eye scan. ...

May 8, 2019

ByOptina Diagnostics

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you